✦ LIBER ✦

Mitochondrial abnormalities in Parkinson's disease

✍ Scribed by Yoshikuni Mizuno; Shin-Ichirou Ikebe; Nobutaka Hattori; Yuko Nakagawa-Hattori; Masashi Tanaka; Takayuki Ozawa

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 130 KB
Volume: 7
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870070512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—mitochondrial abnormalities

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Recently, it was reported that parkinsonlan patients exhibit mitochondrial abnormalhies which might be related to the production of either endogenous or exogenous toxins. We, thus, assessed possible inhibitory effects of dopamine-related compounds on mitochondrial respiration in rat brain. We found

Mitochondrial function in Parkinson's di

Mitochondrial function in Parkinson's disease

✍ Fiorenzo Dagani; Jeffrey J. Anderson; Thomas N. Chase 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 2 views

Reward processing abnormalities in Parki

Reward processing abnormalities in Parkinson's disease

✍ Dimitrios Kapogiannis; Eric Mooshagian; Paul Campion; Jordan Grafman; Trelawny J 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

## Abstract The primary motor cortex is important for motor learning and response selection, functions that require information on the expected and actual outcomes of behavior. Therefore, it should receive signals related to reward. Pathways from reward centers to motor cortex exist in primates. Pr

Parkinson's syndrome and Parkinson's dis

Parkinson's syndrome and Parkinson's disease in mitochondrial disorders

✍ Josef Finsterer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract In the majority of cases, mitochondrial disorders are multisystem conditions that most frequently affect the skeletal muscle, followed by the central nervous system. One of the clinical manifestations of central nervous system involvement is Parkinson's syndrome (PS). Evidence for an as

Mitochondrial DNA analysis in Parkinson'

Mitochondrial DNA analysis in Parkinson's disease

✍ Dr. A. H. V. Schapira; I. J. Holt; M. Sweeney; A. E. Harding; P. Jenner; C. D. M 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

## Abstract The reduced form of nicotinamide adenine dinucleotide coenzyme Q reductase (complex I) activity has recently been shown to be deficient in the substantia nigra of patients dying with Parkinson's disease. This biochemical defect is identical to that produced by the neurotoxin 1‐methyl‐4‐

Mitochondrial therapies for Parkinson's

Mitochondrial therapies for Parkinson's disease

✍ Bobby Thomas; M. Flint Beal 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract Parkinson's disease (PD) is marked by widespread neurodegeneration in the brain in addition to a selective yet prominent and progressive loss of nigrostriatal dopaminergic neurons. Of the multiple theories suggested in the pathogenesis of PD, mitochondrial dysfunction takes a center sta